Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation. - Bell JB; Sheriff S; Goryawala MZ; Cullison K; Azzam GA; Meshman J; Abramowitz MC; Ivan ME; de la Fuente MI; Mellon EA (Radiation oncology (London, England), 2025)